Fig. 4.
Mean (±standard deviation) plasma concentrations of mirabegron after single (Day 1) and multiple oral administration (Days 4–10) of mirabegron oral controlled absorption system in healthy male subjects in Study 1 Part II (n = 8/dose)
Mean (±standard deviation) plasma concentrations of mirabegron after single (Day 1) and multiple oral administration (Days 4–10) of mirabegron oral controlled absorption system in healthy male subjects in Study 1 Part II (n = 8/dose)